Peijun Li

Ms. Peijun Li

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2018 in Clinical Interventions in Aging
Verified
Journal Article
Open access
PDF file
PLPeijun Li
Peijun Li
JLJingxin Liu
Jingxin Liu
YLYufan Lu
Yufan Lu
XLXiaodan Liu
Xiaodan Liu
ZWZhenwei Wang
Zhenwei Wang
WWWeibing Wu
Weibing Wu
Purpose: This study was designed to investigate the effects of long-term home-based Liuzijue exercise combined with clinical guidance in elderly patients with chronic obstructive pulmonary disease (COPD). Methods: Forty patients with COPD at stages II–III of the Global Initiative for Chronic Obstructive Lung Disease were enrolled. The subjects were randomly allocated to the Liuzijue exercise group (LG) or control group (CG) in a 1:1 ratio. Participants in the LG performed six Liuzijue training sessions, including 4 days at home and 2 days in the hospital with clinical guidance for 60 minutes/day for 6 months. Participants in the CG conducted no exercise intervention. In addition, lung function test, 6-minute walking test (6MWT), 30-second sit-to-stand test (30 s SST), and the St George’s Respiratory Questionnaire (SGRQ) were conducted at the baseline and at the end of the intervention. Results: Thirty-six patients completed the study. The patients’ lung function improved significantly (p < 0.05) in the LG as well as the 6MWT, 30 s SST, and SGRQ score (p < 0.01). While the SGRQ total score, activity, and impact scores increased significantly (p < 0.05) in the CG. In addition, there were significant differences between the groups (p < 0.01) in regard to the values of forced expiratory volume in 1 second as a percentage of the predicted volume, 6MWT, 30 s SST, and SGRQ. Conclusions: Long-term home-based Liuzijue exercise combined with clinical guidance can effectively improve the pulmonary function, exercise capacity, and quality of life of elderly patients with moderate to severe COPD.

1 January 2018 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
WWWeibing Wu
Weibing Wu
XLXiaodan Liu
Xiaodan Liu
PLPeijun Li
Peijun Li
NLNing Li
Ning Li
ZWZhenwei Wang
Zhenwei Wang
Objectives. This study aimed to investigate the effect of Liuzijue exercise combined with elastic band resistance exercise on patients with chronic obstructive pulmonary disease (COPD) to provide a convenient, safe, and cost‐effective exercise. Methods. Subjects were randomly divided into the control group (CG), the Liuzijue exercise group (LG), and the Liuzijue exercise combined with elastic band resistance exercise group (LEG), with 20 patients in each group. The LG performed Liuzijue exercise six times a week (two exercise sessions in the hospital and four exercise sessions at home). The LEG includes Liuzijue exercise similar to the LG and elastic band resistance exercise three times a week, with elastic band exercise implemented after Liuzijue exercise. Spirometry, 6‐minute walking test (6MWT), 30‐second sit‐to‐stand test (30 s SST), handgrip strength test, and St. George’s Respiratory Questionnaire (SGRQ) were performed at baseline and at the end of intervention. Results. After six‐month intervention, the forced expiratory volume in 1 second (% predicted), 6‐minute walking distance (6MWD), 6MWD%pred, 30 s SST, and SGRQ were significantly improved in the intervention groups (p < 0.01) and handgrip strength was increased significantly in the LG and LEG (p = 0.03 and p = 0.001, respectively). Furthermore, improvements in 6MWD and SGRQ were distinguished in the intervention groups compared with the CG (p < 0.01). No difference was significant in all of the outcomes between the LG and the LEG. Conclusions. The intervention program of Liuzijue exercise combined with elastic band resistance exercise and Liuzijue exercise only has beneficial effects on COPD patients especially in the aspect of exercise capacity and quality of life.

1 June 2024 in American Journal of Physiology-Lung Cellular and Molecular Physiology
Verified
Journal Article
Closed access
QHQinglan He
Qinglan He
PLPeijun Li
Peijun Li
LHLihua Han
Lihua Han
CYChen Yang
Chen Yang
MJMei ling Jiang
Mei ling Jiang
WWWeibing Wu
Weibing Wu
Chronic exposure to environmental hazards causes airway epithelial dysfunction, primarily impaired physical barriers, immune dysfunction, and repair or regeneration. Impairment of airway epithelial function subsequently leads to exaggerated airway inflammation and remodeling, the main features of chronic obstructive pulmonary disease (COPD). Mitochondrial damage has been identified as one of the mechanisms of airway abnormalities in COPD, which is closely related to airway inflammation and airflow limitation. In this review, we evaluate updated evidence for airway epithelial mitochondrial damage in COPD and focus on the role of mitochondrial damage in airway epithelial dysfunction. In addition, the possible mechanism of airway epithelial dysfunction mediated by mitochondrial damage is discussed in detail, and recent strategies related to airway epithelial-targeted mitochondrial therapy are summarized. Results have shown that dysregulation of mitochondrial quality and oxidative stress may lead to airway epithelial dysfunction in COPD. This may result from mitochondrial damage as a central organelle mediating abnormalities in cellular metabolism. Mitochondrial damage mediates procellular senescence effects due to mitochondrial reactive oxygen species, which effectively exacerbate different types of programmed cell death, participate in lipid metabolism abnormalities, and ultimately promote airway epithelial dysfunction and trigger COPD airway abnormalities. These can be prevented by targeting mitochondrial damage factors and mitochondrial transfer. Thus, because mitochondrial damage is involved in COPD progression as a central factor of homeostatic imbalance in airway epithelial cells, it may be a novel target for therapeutic intervention to restore airway epithelial integrity and function in COPD.

16 August 2022 in Cell Death Discovery
Verified
Journal Article
Open access
PDF file
CLChanjing Liu
Chanjing Liu
PLPeijun Li
Peijun Li
JZJiejiao Zheng
Jiejiao Zheng
YWYingqi Wang
Yingqi Wang
WWWeibing Wu
Weibing Wu
XLXiaodan Liu
Xiaodan Liu
Airflow limitation with intractable progressive mechanisms is the main disease feature of chronic obstructive pulmonary disease (COPD). The pathological process of airflow limitation in COPD involves necroptosis, a form of programmed necrotic cell death with pro-inflammatory properties. In this paper, the correlations of small-airway disease and emphysema with airflow limitation in COPD were firstly reviewed; then, based on this, the effects of necroptosis on small-airway disease and emphysema were analysed, and the possible mechanisms of necroptosis causing airflow limitation in COPD were explored. The results showed that airflow limitation is caused by a combination of small-airway disease and emphysema. In addition, toxic particulate matter stimulates epithelial cells to trigger necroptosis, and necroptosis promotes the expulsion of cell contents, the abnormal hyperplasia of pro-inflammatory mediators and the insufficient clearance of dead cells by macrophages; these processes, coupled with the interaction of necroptosis and oxidative stress, collectively result in small-airway disease and emphysema in COPD.

1 January 2020 in BioMed Research International
Verified
Journal Article
Open access
PDF file
JLJian Li
Jian Li
YLYufan Lu
Yufan Lu
NLNing Li
Ning Li
PLPeijun Li
Peijun Li
ZWZhengrong Wang
Zhengrong Wang
WWWeibing Wu
Weibing Wu
Chronic obstructive pulmonary disease (COPD) features chronic inflammatory reactions of both intra‐ and extrapulmonary nature. Moreover, COPD is associated with abnormal glucose and lipid metabolism in patients, which influences the prognosis and chronicity of this disease. Abnormal glucose and lipid metabolism are also closely related to inflammation processes. Further insights into the interactions of inflammation and glucose and lipid metabolism might therefore inspire novel therapeutic interventions to promote lung rehabilitation. Chemerin, as a recently discovered adipokine, has been shown to play a role in inflammatory response and glucose and lipid metabolism in many diseases (including COPD). Chemerin recruits inflammatory cells to sites of inflammation during the early stages of COPD, leading to endothelial barrier dysfunction, early vascular remodeling, and angiogenesis. Moreover, it supports the recruitment of antigen‐presenting cells that guide immune cells as part of the body’s inflammatory responses. Chemerin also regulates metabolism via activation of its cognate receptors. Glucose homeostasis is affected via effects on insulin secretion and sensitivity, and lipid metabolism is changed by increased transformation of preadipocytes to mature adipocytes through chemerin‐binding receptors. Controlling chemerin signaling may be a promising approach to improve various aspects of COPD‐related dysfunction. Importantly, several studies indicate that chemerin expression in vivo is influenced by exercise. Although available evidence is still limited, therapeutic alterations of chemerin activity may be a promising target of therapeutic approaches aimed at the rehabilitation of COPD patients based on exercises. In conclusion, chemerin plays an essential role in COPD, especially in the inflammatory responses and metabolism, and has a potential to become a target for, and a biomarker of, curative mechanisms underlying exercise‐mediated lung rehabilitation.

16 October 2025 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
HLHui Li
Hui Li
YWYingqi Wang
Yingqi Wang
HDHongxia Duan
Hongxia Duan
YBYidie Bao
Yidie Bao
XDXinliao Deng
Xinliao Deng
XLXiaodan Liu
Xiaodan Liu
Background: Chronic Obstructive Pulmonary Disease (COPD) is a leading cause of global mortality, characterized by chronic inflammation and abnormal immune responses in the lower airways. Recent studies have highlighted the critical role of immune function in the pathogenesis and progression of COPD. The disease is characterized by abnormal immune responses in the lower respiratory tract, with its progression associated with the infiltration of innate and adaptive inflammatory immune cells into the lungs and the formation of lymphoid follicles, mediated by cytokines and inflammasomes. Increasing evidence suggests that cell-mediated immunity has an important role in the pathogenesis of COPD, which is characterized by immune senescence leading to decreased resistance to infection, enhanced neutrophil and macrophage activation, T-cell infiltration, and aberrant B-cell activity, all of which combine to contribute to airway inflammation and lung injury in patients with COPD.Objective: This review aimed to explore the pivotal role of the immune system in COPD and its therapeutic potential.Methods: We reviewed, categorized, and summarized literature on immunity and COPD published in the last five years from Web of Science and PubMed databases.Results: This study elucidates the pivotal role of immune dysregulation in COPD pathogenesis, particularly the dysfunctional transition from innate to adaptive immunity. We delineate how specific immune cell populations—including macrophages, neutrophils, and T-lymphocytes—contribute to sustained airway inflammation and lung injury in COPD through aberrant activation, infiltration, and impaired function. Mechanistically, key features of this dysregulation involve aberrant cytokine signaling pathways and defective resolution of inflammation. These insights reveal potential therapeutic targets for immunomodulatory strategies aimed at interrupting the chronic inflammatory cascade, restoring immune homeostasis, and mitigating infection susceptibility in COPD. Promising approaches highlighted include targeting specific cytokines, modulating macrophage polarization states, and enhancing mucosal immune defenses.